{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T02:19:36Z","timestamp":1786760376315,"version":"build-2736575974"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s42000-022-00386-7","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T23:03:51Z","timestamp":1657839831000},"page":"555-571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lipodystrophy-associated progeroid syndromes"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2852-7851","authenticated-orcid":false,"given":"David","family":"Ara\u00fajo-Vilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00eda","family":"Fern\u00e1ndez-Pombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cobelo-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"S\u00e1nchez-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"386_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2020.103995","volume":"63","author":"RCM Hennekam","year":"2020","unstructured":"Hennekam RCM (2020) The external phenotype of aging. Eur J Med Genet 63:103995. https:\/\/doi.org\/10.1016\/j.ejmg.2020.103995","journal-title":"Eur J Med Genet"},{"key":"386_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000516668","volume":"68","author":"H Chen","year":"2022","unstructured":"Chen H, Liu O, Chen S, Zhou Y (2022) Aging and mesenchymal stem cells: therapeutic opportunities and challenges in the older group. Gerontology 68:339\u2013352. https:\/\/doi.org\/10.1159\/000516668","journal-title":"Gerontology"},{"key":"386_CR3","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153:1194\u20131217. https:\/\/doi.org\/10.1016\/j.cell.2013.05.039","journal-title":"Cell"},{"key":"386_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.cell.2005.01.031","volume":"120","author":"GM Martin","year":"2005","unstructured":"Martin GM (2005) Genetic modulation of senescent phenotypes in Homo sapiens. Cell 120:523\u2013532. https:\/\/doi.org\/10.1016\/j.cell.2005.01.031","journal-title":"Cell"},{"key":"386_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2020.104028","volume":"63","author":"RCM Hennekam","year":"2020","unstructured":"Hennekam RCM (2020) Pathophysiology of premature aging characteristics in Mendelian progeroid disorders. Eur J Med Genet 63:104028. https:\/\/doi.org\/10.1016\/j.ejmg.2020.104028","journal-title":"Eur J Med Genet"},{"key":"386_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40618-018-0887-z","volume":"42","author":"D Araujo-Vilar","year":"2019","unstructured":"Araujo-Vilar D, Santini F (2019) Diagnosis and treatment of lipodystrophy: a step-by-step approach. J Endocrinol Invest 42:61\u201373. https:\/\/doi.org\/10.1007\/s40618-018-0887-z","journal-title":"J Endocrinol Invest"},{"key":"386_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/19491034.2018.1454167","volume":"9","author":"C Guill\u00edn-Amarelle","year":"2018","unstructured":"Guill\u00edn-Amarelle C, Fern\u00e1ndez-Pombo A, S\u00e1nchez-Iglesias S, Ara\u00fajo-Vilar D (2018) Lipodystrophic laminopathies: diagnostic clues. Nucleus 9:249\u2013260. https:\/\/doi.org\/10.1080\/19491034.2018.1454167","journal-title":"Nucleus"},{"key":"386_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1152\/physrev.00047.2005","volume":"86","author":"JL Broers","year":"2006","unstructured":"Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ (2006) Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 86:967\u20131008. https:\/\/doi.org\/10.1152\/physrev.00047.2005","journal-title":"Physiol Rev"},{"key":"386_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fgene.2019.00455","volume":"10","author":"VV Ashapkin","year":"2019","unstructured":"Ashapkin VV, Kutueva LI, Kurchashova SY, Kireev II (2019) Are there common mechanisms between the Hutchinson-Gilford progeria syndrome and natural aging? Front Genet 10:455. https:\/\/doi.org\/10.3389\/fgene.2019.00455","journal-title":"Front Genet"},{"key":"386_CR10","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1126\/science.1084125","volume":"300","author":"A De Sandre-Giovannoli","year":"2003","unstructured":"De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, L\u00e9vy N (2003) Lamin a truncation in Hutchinson-Gilford progeria. Science 300:2055. https:\/\/doi.org\/10.1126\/science.1084125","journal-title":"Science"},{"key":"386_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature01629","volume":"423","author":"M Eriksson","year":"2003","unstructured":"Eriksson M, Brown WT, Gordon LB et al (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423:293\u2013298. https:\/\/doi.org\/10.1038\/nature01629","journal-title":"Nature"},{"key":"386_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cge.13837","volume":"99","author":"F Schnabel","year":"2021","unstructured":"Schnabel F, Kornak U, Wollnik B (2021) Premature aging disorders: a clinical and genetic compendium. Clin Genet 99:3\u201328. https:\/\/doi.org\/10.1111\/cge.13837","journal-title":"Clin Genet"},{"key":"386_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1056\/NEJMoa0706898","volume":"358","author":"MA Merideth","year":"2008","unstructured":"Merideth MA, Gordon LB, Clauss S et al (2008) Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 358:592\u2013604. https:\/\/doi.org\/10.1056\/NEJMoa0706898","journal-title":"N Engl J Med"},{"key":"386_CR14","unstructured":"Gordon LB, Brown WT, Collins FS (2019) Hutchinson-Gilford progeria syndrome. In: Adam MP, Ardinger HH Pagon SE, Wallace, L. J. H. Bean, Stephens K, Amemiya A (eds) GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132019. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1121\/"},{"key":"386_CR15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1086\/341908","volume":"71","author":"G Novelli","year":"2002","unstructured":"Novelli G, Muchir A, Sangiuolo F (2002) Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A\/C. Am J Hum Genet 71:426\u2013431. https:\/\/doi.org\/10.1086\/341908","journal-title":"Am J Hum Genet"},{"key":"386_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00418-012-0977-5","volume":"138","author":"D Camozzi","year":"2012","unstructured":"Camozzi D, D\u2019Apice MR, Schena E, Cenni V, Columbaro M, Capanni C, Maraldi NM, Squarzoni E, Ortolani M, Novelli G, Lattanzi G (2012) Altered chromatin organization and SUN2 localization in mandibuloacral dysplasia are rescued by drug treatment. Histochem Cell Biol 138:643\u2013651. https:\/\/doi.org\/10.1007\/s00418-012-0977-5","journal-title":"Histochem Cell Biol"},{"key":"386_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2017.12.001","volume":"42","author":"V Cenni","year":"2018","unstructured":"Cenni V, D\u2019Apice MR, Garagnani P, Columbaro M, Novelli G, Franceschi C, Lattanzi G (2018) Mandibuloacral dysplasia: a premature ageing disease with aspects of physiological ageing. Ageing Res Rev 42:1\u201313. https:\/\/doi.org\/10.1016\/j.arr.2017.12.001","journal-title":"Ageing Res Rev"},{"key":"386_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/ijms20040847","volume":"20","author":"F Chiarini","year":"2019","unstructured":"Chiarini F, Evangelisti C, Cenni V, Fazio A, Paganelli F, Martelli AM, Lattanzi G (2019) The cutting edge: the role of mTOR signaling in laminopathies. Int J Mol Sci 20:847. https:\/\/doi.org\/10.3390\/ijms20040847","journal-title":"Int J Mol Sci"},{"key":"386_CR19","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/genes12101508","volume":"12","author":"I J\u00e9ru","year":"2021","unstructured":"J\u00e9ru I, Nabil A, El-Makkawy G, Lascols O, Vigouroux C, Abdalla E (2021) Two decades after mandibuloacral dysplasia discovery: additional cases and comprehensive view of disease characteristics. Genes (Basel) 12:1508. https:\/\/doi.org\/10.3390\/genes12101508","journal-title":"Genes (Basel)"},{"key":"386_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104138","volume":"64","author":"R Sakka","year":"2021","unstructured":"Sakka R, Marmouch H, Trabelsi M, Achour A, Golli M, Hannachi I, Kerkeni E, Monastiri K, Maazoul F, M\u2019rad R (2021) Mandibuloacral dysplasia type A in five tunisian patients. Eur J Med Genet 64:104138. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104138","journal-title":"Eur J Med Genet"},{"key":"386_CR21","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1210\/jc.2017-02078","volume":"103","author":"I Hussain","year":"2018","unstructured":"Hussain I, Patni N, Ueda M et al (2018) A novel generalized lipodystrophy-associated progeroid syndrome due to recurrent heterozygous LMNA p. T10I mutation. J Clin Endocrinol Metab 103:1005\u20131014. https:\/\/doi.org\/10.1210\/jc.2017-02078","journal-title":"J Clin Endocrinol Metab"},{"key":"386_CR22","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1210\/jc.2009-0472","volume":"94","author":"A Garg","year":"2009","unstructured":"Garg A, Subramanyam L, Agarwal AK, Simha V, Levine B, D\u2019Apice MR, Novelli G, Crow Y (2009) Atypical progeroid syndrome due to heterozygous missense LMNA mutations. J Clin Endocrinol Metab 94:4971\u20134983. https:\/\/doi.org\/10.1210\/jc.2009-0472","journal-title":"J Clin Endocrinol Metab"},{"key":"386_CR23","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1002\/ajmg.a.35557","volume":"158A","author":"Y Doubaj","year":"2012","unstructured":"Doubaj Y, De Sandre-Giovannoli A, Esteves-Vieira V, Navarro CL, Elalaoui SC, Tajir M, L\u00e9vy N, Sefiani A (2012) An inherited LMNA gene mutation in atypical progeria syndrome. Am J Med Genet A 158A:2881\u20132887. https:\/\/doi.org\/10.1002\/ajmg.a.35557","journal-title":"Am J Med Genet A"},{"key":"386_CR24","doi-asserted-by":"publisher","first-page":"bvaa104","DOI":"10.1210\/jendso\/bvaa104","volume":"4","author":"I Hussain","year":"2020","unstructured":"Hussain I, Jin RR, Baum HBA et al (2020) Multisystem progeroid syndrome with lipodystrophy, cardiomyopathy, and nephropathy due to an LMNA p.R349W variant. J Endocr Soc 4:bvaa104. https:\/\/doi.org\/10.1210\/jendso\/bvaa104","journal-title":"J Endocr Soc"},{"key":"386_CR25","doi-asserted-by":"publisher","first-page":"bvaa108","DOI":"10.1210\/jendso\/bvaa108","volume":"4","author":"S Magno","year":"2020","unstructured":"Magno S, Ceccarini G, Pelosini C et al (2020) Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation. J Endocr Soc 4:bvaa108. https:\/\/doi.org\/10.1210\/jendso\/bvaa108","journal-title":"J Endocr Soc"},{"key":"386_CR26","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/hmg\/ddg213","volume":"12","author":"AK Agarwal","year":"2003","unstructured":"Agarwal AK, Fryns JP, Auchus RJ, Garg A (2003) Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 12:1995\u20132001. https:\/\/doi.org\/10.1093\/hmg\/ddg213","journal-title":"Hum Mol Genet"},{"key":"386_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13023-019-1269-0","volume":"14","author":"MM Hitzert","year":"2019","unstructured":"Hitzert MM, van der Crabben SN, Baldewsingh G, Ploos van Amstel HK, van den Wijngaard A, van Ravenswaaij-Arts CMA, Zijlmans CWR (2019) Mandibuloacral dysplasia type B (MADB): a cohort of eight patients from Suriname with a homozygous founder mutation in ZMPSTE24 (FACE1), clinical diagnostic criteria and management guidelines. Orphanet J Rare Dis 14:294. https:\/\/doi.org\/10.1186\/s13023-019-1269-0","journal-title":"Orphanet J Rare Dis"},{"key":"386_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2310\/6650.2006.05068","volume":"54","author":"AK Agarwal","year":"2006","unstructured":"Agarwal AK, Zhou XJ, Hall RK, Nicholls K, Bankier A, Van Esch H, Fryns JP, Garg A (2006) Focal segmental glomerulosclerosis in patients with mandibuloacral dysplasia owing to ZMPSTE24 deficiency. J Investig Med 54:208\u2013213. https:\/\/doi.org\/10.2310\/6650.2006.05068","journal-title":"J Investig Med"},{"key":"386_CR29","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ajhg.2011.04.010","volume":"88","author":"XS Puente","year":"2011","unstructured":"Puente XS, Quesada V, Osorio FG et al (2011) Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am J Hum Genet 88:650\u20136. https:\/\/doi.org\/10.1016\/j.ajhg.2011.04.010","journal-title":"Am J Hum Genet"},{"key":"386_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.775441","volume":"9","author":"M Rose","year":"2021","unstructured":"Rose M, Bai B, Tang M, Cheong CM, Beard S, Burgess JT, Adams MN, O\u2019Byrne KJ, Richard DJ, Gandhi NS, Bolderson E (2021) The impact of rare human variants on barrier-to-auto-integration factor 1 (Banf1) structure and function. Front Cell Dev Biol 9:775441. https:\/\/doi.org\/10.3389\/fcell.2021.775441","journal-title":"Front Cell Dev Biol"},{"key":"386_CR31","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1002\/ajmg.a.34249","volume":"155","author":"R Cabanillas","year":"2011","unstructured":"Cabanillas R, Cadi\u00f1anos J, Villameytide JAF, P\u00e9rez M, Longo J, Richard JM, Alvarez R, Dur\u00e1n NS, Ill\u00e1n R, Gonz\u00e1lez DJ, L\u00f3pez-Ot\u00edn C (2011) N\u00e9stor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations. Am J Med Genet Part A 155:2617\u20132625. https:\/\/doi.org\/10.1002\/ajmg.a.34249","journal-title":"Am J Med Genet Part A"},{"key":"386_CR32","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1002\/ajmg.a.61777","volume":"182","author":"HG Fisher","year":"2020","unstructured":"Fisher HG, Patni N, Scheuerle AE (2020) An additional case of N\u00e9stor-Guillermo progeria syndrome diagnosed in early childhood. Am J Med Genet A 182:2399\u20132402. https:\/\/doi.org\/10.1002\/ajmg.a.61777","journal-title":"Am J Med Genet A"},{"key":"386_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nature10760","volume":"481","author":"CJ Lord","year":"2012","unstructured":"Lord CJ, Ashworth A (2012) The DNA damage response and cancer therapy. Nature 481:287\u2013294. https:\/\/doi.org\/10.1038\/nature10760","journal-title":"Nature"},{"key":"386_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.640755","volume":"9","author":"H Lu","year":"2021","unstructured":"Lu H, Davis AJ (2021) Human RecQ helicases in DNA double-strand break repair. Front Cell Dev Biol 9:640755. https:\/\/doi.org\/10.3389\/fcell.2021.640755","journal-title":"Front Cell Dev Biol"},{"key":"386_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000516386","volume":"161","author":"R Gudmundsrud","year":"2021","unstructured":"Gudmundsrud R, Skj\u00e5nes TH, Gilmour BC, Caponio D, Lautrup S, Fang EF (2021) Crosstalk among DNA damage, mitochondrial dysfunction, impaired mitophagy, stem cell attrition, and senescence in the accelerated ageing disorder Werner syndrome. Cytogenet Genome Res 161:297\u2013304. https:\/\/doi.org\/10.1159\/000516386","journal-title":"Cytogenet Genome Res"},{"key":"386_CR36","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaa1356","volume":"348","author":"W Zhang","year":"2015","unstructured":"Zhang W, Li J, Suzuki K et al (2015) Aging stem cells. A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging. Science 348:1160\u20131163. https:\/\/doi.org\/10.1126\/science.aaa1356","journal-title":"Science"},{"key":"386_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.18632\/aging.100315","volume":"3","author":"N Ishikawa","year":"2011","unstructured":"Ishikawa N, Nakamura K, Izumiyama-Shimomura N et al (2011) Accelerated in vivo epidermal telomere loss in Werner syndrome. Aging (Albany NY) 3:417\u2013429. https:\/\/doi.org\/10.18632\/aging.100315","journal-title":"Aging (Albany NY)"},{"key":"386_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059709","volume":"8","author":"JM Lauper","year":"2013","unstructured":"Lauper JM, Krause A, Vaughan TL, Monnat RJ Jr (2013) Spectrum and risk of neoplasia in Werner syndrome: a systematic review. PLoS ONE 8:e59709. https:\/\/doi.org\/10.1371\/journal.pone.0059709","journal-title":"PLoS ONE"},{"key":"386_CR39","doi-asserted-by":"publisher","first-page":"7490","DOI":"10.1038\/s41598-020-64136-8","volume":"10","author":"KJ Goh","year":"2020","unstructured":"Goh KJ, Chen JH, Rocha N, Semple RK, RK, (2020) Human pluripotent stem cell-based models suggest preadipocyte senescence as a possible cause of metabolic complications of Werner and Bloom Syndromes. Sci Rep 10:7490. https:\/\/doi.org\/10.1038\/s41598-020-64136-8","journal-title":"Sci Rep"},{"key":"386_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.redox.2016.12.030","volume":"11","author":"M Maciejczyk","year":"2017","unstructured":"Maciejczyk M, Mikoluc B, Pietrucha B, Heropolitanska-Pliszka E, Pac M, Motkowski R, Car H (2017) Oxidative stress, mitochondrial abnormalities and antioxidant defense in Ataxia-telangiectasia, Bloom syndrome and Nijmegen breakage syndrome. Redox Biol 11:375\u2013383. https:\/\/doi.org\/10.1016\/j.redox.2016.12.030","journal-title":"Redox Biol"},{"key":"386_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000452082","volume":"8","author":"C Cunniff","year":"2017","unstructured":"Cunniff C, Bassetti JA, Ellis NA (2017) Bloom\u2019s syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition. Mol Syndromol 8:4\u201323. https:\/\/doi.org\/10.1159\/000452082","journal-title":"Mol Syndromol"},{"key":"386_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ajhg.2019.06.005","volume":"105","author":"V Tiwari","year":"2019","unstructured":"Tiwari V, Wilson DM 3rd (2019) DNA damage and associated DNA repair defects in disease and premature aging. Am J Hum Genet 105:237\u2013257. https:\/\/doi.org\/10.1016\/j.ajhg.2019.06.005","journal-title":"Am J Hum Genet"},{"key":"386_CR43","doi-asserted-by":"publisher","unstructured":"Pascucci B, Fragale A, Marabitti V, Leuzzi G, Calcagnile AS, Parlanti E, Franchitto A, Dogliotti E, D\u2019Errico M (2018) CSA and CSB play a role in the response to DNA breaks. Oncotarget 9:11581\u201311591. https:\/\/doi.org\/10.18632\/oncotarget.24342","DOI":"10.18632\/oncotarget.24342"},{"key":"386_CR44","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41467-017-02114-x","volume":"8","author":"NL Batenburg","year":"2017","unstructured":"Batenburg NL, Walker JR, Noordermeer SM, Moatti N, Durocher D, Zhu XD (2017) ATM and CDK2 control chromatin remodeler CSB to inhibit RIF1 in DSB repair pathway choice. Nat Commun 8:1921\u20131921. https:\/\/doi.org\/10.1038\/s41467-017-02114-x","journal-title":"Nat Commun"},{"key":"386_CR45","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1093\/nar\/gkab085","volume":"49","author":"V Tiwari","year":"2021","unstructured":"Tiwari V, Baptiste BA, Okur MN, Bohr VA (2021) Current and emerging roles of Cockayne syndrome group B (CSB) protein. Nucleic Acids Res 49:2418\u20132434. https:\/\/doi.org\/10.1093\/nar\/gkab085","journal-title":"Nucleic Acids Res"},{"key":"386_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.arr.2016.08.002","volume":"33","author":"AC Karikkineth","year":"2017","unstructured":"Karikkineth AC, Scheibye-Knudsen M, Fivenson E, Croteau DL, Bohr VA (2017) Cockayne syndrome: clinical features, model systems and pathways. Ageing Res Rev 33:3\u201317. https:\/\/doi.org\/10.1016\/j.arr.2016.08.002","journal-title":"Ageing Res Rev"},{"key":"386_CR47","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ng.3103","volume":"46","author":"D Lessel","year":"2014","unstructured":"Lessel D, Vaz B, Halder S et al (2014) Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features. Nat Genet 46:1239\u20131244. https:\/\/doi.org\/10.1038\/ng.3103","journal-title":"Nat Genet"},{"key":"386_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.tibs.2020.10.007","volume":"46","author":"A Ruggiano","year":"2021","unstructured":"Ruggiano A, Ramadan K (2021) The trinity of SPRTN protease regulation. Trends Biochem Sci 46:2\u20134. https:\/\/doi.org\/10.1016\/j.tibs.2020.10.007","journal-title":"Trends Biochem Sci"},{"key":"386_CR49","doi-asserted-by":"publisher","unstructured":"Ruijs MWG, van Andel RNJ, Oshima J, Madan K, Nieuwint AWM, Aalfs CM. Atypical progeroid syndrome: an unknown helicase gene defect? Am J Med Genet A 116A:295\u20139. https:\/\/doi.org\/10.1002\/ajmg.a.10730.","DOI":"10.1002\/ajmg.a.10730"},{"key":"386_CR50","doi-asserted-by":"publisher","unstructured":"Murdocca M, Spitalieri P, De Masi C et al (2021) Functional analysis of POLD1 p.ser605del variant: the aging phenotype of MDPL syndrome is associated with an impaired DNA repair capacity. Aging (Albany NY) 13:4926\u20134945. https:\/\/doi.org\/10.18632\/aging.202680","DOI":"10.18632\/aging.202680"},{"key":"386_CR51","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/ng.2670","volume":"45","author":"MN Weedon","year":"2013","unstructured":"Weedon MN, Ellard S, Brindle MJ et al (2013) An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nat Genet 45:947\u2013950. https:\/\/doi.org\/10.1038\/ng.2670","journal-title":"Nat Genet"},{"key":"386_CR52","doi-asserted-by":"publisher","unstructured":"Murdocca M, Spitalieri P, Cappello A, Colasuonno F, Moreno S, Candi E, D\u2019Apice MR, Novelli G, Sangiuolo F (2022) Mitochondrial dysfunction in mandibular hypoplasia, deafness and progeroid features with concomitant lipodystrophy (MDPL) patients. Aging (Albany NY). 14:1651\u20131664. https:\/\/doi.org\/10.18632\/aging.203910","DOI":"10.18632\/aging.203910"},{"key":"386_CR53","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1002\/ajmg.a.37960","volume":"170","author":"AM Jay","year":"2016","unstructured":"Jay AM, Conway RL, Thiffault I, Saunders C, Farrow E, Adams J, Toriello HV (2016) Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A. Am J Med Genet A 170:3343\u20133346. https:\/\/doi.org\/10.1002\/ajmg.a.37960","journal-title":"Am J Med Genet A"},{"key":"386_CR54","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.tcb.2018.03.007","volume":"28","author":"V Tiku","year":"2018","unstructured":"Tiku V (2018) Antebi A (2018) Nucleolar function in lifespan regulation. Trends Cell Biol 28:662\u2013672. https:\/\/doi.org\/10.1016\/j.tcb.2018.03.007","journal-title":"Trends Cell Biol"},{"key":"386_CR55","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/ajmg.a.38246","volume":"173","author":"S Paolacci","year":"2017","unstructured":"Paolacci S, Bertola D, Franco J, Mohammed S, Tartaglia M, Wollnik B, Hennekam RC (2017) Wiedemann-Rautenstrauch syndrome: a phenotype analysis. Am J Med Genet A 173:1763\u20131772. https:\/\/doi.org\/10.1002\/ajmg.a.38246","journal-title":"Am J Med Genet A"},{"key":"386_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111360","volume":"192","author":"C B\u00e1ez-Becerra","year":"2020","unstructured":"B\u00e1ez-Becerra C, Valencia-Rinc\u00f3n E, Vel\u00e1squez-M\u00e9ndez K, Ram\u00edrez-Su\u00e1rez NJ, Guevara C, Sandoval-Hernandez A, Arboleda-Bustos CE, Olivos-Cisneros L, Guti\u00e9rrez-Ospina G, Arboleda H, Arboleda G (2020) Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts. Mech Ageing Dev 192:111360. https:\/\/doi.org\/10.1016\/j.mad.2020.111360","journal-title":"Mech Ageing Dev"},{"key":"386_CR57","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/cdd.2011.139","volume":"19","author":"J Traba","year":"2012","unstructured":"Traba J, Del Arco A, Duchen MR, Szabadkai G, Satr\u00fastegui J (2012) SCaMC-1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP\/ADP-mediated matrix Ca(2+) buffering. Cell Death Differ 19:650\u2013660. https:\/\/doi.org\/10.1038\/cdd.2011.139","journal-title":"Cell Death Differ"},{"key":"386_CR58","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ajhg.2017.09.016","volume":"101","author":"N Ehmke","year":"2017","unstructured":"Ehmke N, Graul-Neumann L, Smorag L et al (2017) De novo mutations in SLC25A24 cause a craniosynostosis syndrome with hypertrichosis, progeroid appearance, and mitochondrial Dysfunction. Am J Hum Genet 101:833\u2013843. https:\/\/doi.org\/10.1016\/j.ajhg.2017.09.016","journal-title":"Am J Hum Genet"},{"key":"386_CR59","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ajhg.2017.09.017","volume":"101","author":"K Writzl","year":"2017","unstructured":"Writzl K, Maver A, Lidija Kova\u010di\u010d L et al (2017) De novo mutations in SLC25A24 cause a disorder characterized by early aging, bone dysplasia, characteristic face, and early demise. Am J Hum Genet 101:844\u2013855. https:\/\/doi.org\/10.1016\/j.ajhg.2017.09.017","journal-title":"Am J Hum Genet"},{"key":"386_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/(SICI)1097-4644(19990701)74:1<11::AID-JCB2>3.0.CO;2-V","volume":"74","author":"LC Armstrong","year":"1999","unstructured":"Armstrong LC, Saenz AJ, Bornstein P (1999) Metaxin 1 interacts with metaxin 2, a novel related protein associated with the mammalian mitochondrial outer membrane. J Cell Biochem 74:11\u201322","journal-title":"J Cell Biochem"},{"key":"386_CR61","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1038\/s41467-020-18146-9","volume":"11","author":"S Elouej","year":"2020","unstructured":"Elouej S, Harhouri K, Mao ML et al (2020) Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology. Nat Commun 11:4589. https:\/\/doi.org\/10.1038\/s41467-020-18146-9","journal-title":"Nat Commun"},{"key":"386_CR62","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ajhg.2015.08.001","volume":"97","author":"B Fischer-Zirnsak","year":"2015","unstructured":"Fischer-Zirnsak B, Escande-Beillard N, Ganesh J et al (2015) Recurrent de novo mutations affecting residue Arg138 of pyrroline-5-carboxylate synthase cause a progeroid form of autosomal-dominant cutis laxa. Am J Hum Genet 97:483\u2013492. https:\/\/doi.org\/10.1016\/j.ajhg.2015.08.001","journal-title":"Am J Hum Genet"},{"issue":"9","key":"386_CR63","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ng.413","volume":"41","author":"B Reversade","year":"2009","unstructured":"Reversade B, Escande-Beillard N, Dimopoulos A et al (2009) Mutations in PYCR1 cause cutis laxa with progeroid features. Nat Genet 41(9):1016\u20131021. https:\/\/doi.org\/10.1038\/ng.413","journal-title":"Nat Genet"},{"key":"386_CR64","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/brain\/awv143","volume":"138","author":"M Coutelier","year":"2015","unstructured":"Coutelier M, Goizet C, Durr A et al (2015) Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. Brain 138:2191\u20132205. https:\/\/doi.org\/10.1093\/brain\/awv143","journal-title":"Brain"},{"key":"386_CR65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","volume":"93","author":"C Thauvin-Robinet","year":"2013","unstructured":"Thauvin-Robinet C, Auclair M, Diploma L et al (2013) PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet 93:141\u2013149. https:\/\/doi.org\/10.1016\/j.ajhg.2013.05.019","journal-title":"Am J Hum Genet"},{"key":"386_CR66","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"JA Engelman","year":"2006","unstructured":"Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606\u2013619. https:\/\/doi.org\/10.1038\/nrg1879","journal-title":"Nat Rev Genet"},{"key":"386_CR67","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1128\/MCB.06361-11","volume":"32","author":"A Mukherjee","year":"2012","unstructured":"Mukherjee A, Rotwein P (2012) Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development. Mol Cell Biol 32:490\u2013500. https:\/\/doi.org\/10.1128\/MCB.06361-11","journal-title":"Mol Cell Biol"},{"key":"386_CR68","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000515390","volume":"68","author":"TA Donlon","year":"2022","unstructured":"Donlon TA, Chen R, Masaki KH, Willcox BJ, Morris BJ (2022) Association with longevity of phosphatidylinositol 3-kinase regulatory subunit 1 gene variants stems from protection against mortality risk in men with cardiovascular disease. Gerontology 68:162\u2013170. https:\/\/doi.org\/10.1159\/000515390","journal-title":"Gerontology"},{"key":"386_CR69","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajhg.2013.05.023","volume":"93","author":"KK Chudasama","year":"2013","unstructured":"Chudasama KK, Winnay J, Johansson S et al (2013) SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. Am J Hum Genet 93:150\u2013157. https:\/\/doi.org\/10.1016\/j.ajhg.2013.05.023","journal-title":"Am J Hum Genet"},{"key":"386_CR70","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41431-018-0323-z","volume":"27","author":"C Bredrup","year":"2019","unstructured":"Bredrup C, Stokowy T, McGaughran J et al (2019) A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome. Eur J Hum Genet 27:574\u2013581. https:\/\/doi.org\/10.1038\/s41431-018-0323-z","journal-title":"Eur J Hum Genet"},{"key":"386_CR71","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141:1117\u20131134. https:\/\/doi.org\/10.1016\/j.cell.2010.06.011","journal-title":"Cell"},{"key":"386_CR72","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1101\/gad.1653708","volume":"22","author":"J Andrae","year":"2008","unstructured":"Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276\u20131312. https:\/\/doi.org\/10.1101\/gad.1653708","journal-title":"Genes Dev"},{"key":"386_CR73","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ajmg.a.62558","volume":"188","author":"B Aggarwal","year":"2022","unstructured":"Aggarwal B, Correa ARE, Gupta N, Jana M, Kabra M (2022) First case report of Penttinen syndrome from India. Am J Med Genet A 188:683\u2013687. https:\/\/doi.org\/10.1002\/ajmg.a.62558","journal-title":"Am J Med Genet A"},{"key":"386_CR74","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ajhg.2014.12.011","volume":"96","author":"A Masotti","year":"2015","unstructured":"Masotti A, Uva P, Davis-Keppel L et al (2015) Keppen-Lubinsky syndrome is caused by mutations in the inwardly rectifying K+ channel encoded by KCNJ6. Am J Hum Genet 96:295\u2013300. https:\/\/doi.org\/10.1016\/j.ajhg.2014.12.011","journal-title":"Am J Hum Genet"},{"key":"386_CR75","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1073\/pnas.1109099109","volume":"109","author":"A Cooper","year":"2012","unstructured":"Cooper A, Grigoryan G, Guy-David L, Tsoory MM, Chen A, Reuveny E (2012) Trisomy of the G protein-coupled K+ channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice. Proc Natl Acad Sci 109:2642\u20132647. https:\/\/doi.org\/10.1073\/pnas.1109099109","journal-title":"Proc Natl Acad Sci"},{"key":"386_CR76","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fgene.2020.00614","volume":"11","author":"M Kessi","year":"2020","unstructured":"Kessi M, Chen B, Peng J, Tang Y, Olatoutou E, He F, Yang L, Yin F (2020) Intellectual disability and potassium channelopathies: a systematic review. Front Genet 11:614. https:\/\/doi.org\/10.3389\/fgene.2020.00614","journal-title":"Front Genet"},{"key":"386_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003737","volume":"3","author":"S Sundelacruz","year":"2008","unstructured":"Sundelacruz S, Levin M, Kaplan DL (2008) Membrane potential controls adipogenic and osteogenic differentiation of mesenchymal stem cells. PLoS ONE 3:e3737. https:\/\/doi.org\/10.1371\/journal.pone.0003737","journal-title":"PLoS ONE"},{"key":"386_CR78","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2018.05.031","volume":"384","author":"GA Horvath","year":"2018","unstructured":"Horvath GA, Zhao Y, Tarailo-Graovac M et al (2018) Gain-of-function KCNJ6 mutation in a severe hyperkinetic movement disorder phenotype. Neuroscience 384:152\u2013164. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.05.031","journal-title":"Neuroscience"},{"key":"386_CR79","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ajhg.2018.10.013","volume":"103","author":"L Xu","year":"2018","unstructured":"Xu L, Jensen H, Johnston JJ et al (2018) Recurrent, activating variants in the receptor tyrosine kinase DDR2 cause Warburg-Cinotti syndrome. Am J Hum Genet 103:976\u2013983. https:\/\/doi.org\/10.1016\/j.ajhg.2018.10.013","journal-title":"Am J Hum Genet"},{"key":"386_CR80","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1002\/ajmg.a.31543","volume":"140","author":"M Warburg","year":"2006","unstructured":"Warburg M, Ullman S, Jensen H, Pedersen H, Kobayashi T, Russell B, Tranebjaerg L, Richard G, Br\u00f8ndum-Nielsen K (2006) Blepharophimosis, corneal vascularization, deafness, and acroosteolysis: a \u201cnew\u201d syndrome? Am J Med Genet A 140:2709\u20132713. https:\/\/doi.org\/10.1002\/ajmg.a.31543","journal-title":"Am J Med Genet A"},{"key":"386_CR81","doi-asserted-by":"publisher","unstructured":"Cinotti E, Ferrero G, Paparo F, Papadia M, Faravelli F, Rongioletti F, Traverso C, Di Maria E. Arthropathy, osteolysis, keloids, relapsing conjunctival pannus and gingival overgrowth: a variant of polyfibromatosis? Am J Med Genet A 161A:1214\u201320. https:\/\/doi.org\/10.1002\/ajmg.a.35908","DOI":"10.1002\/ajmg.a.35908"},{"key":"386_CR82","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1002\/ajmg.a.33690","volume":"152A","author":"LM Graul-Neumann","year":"2010","unstructured":"Graul-Neumann LM, Kienitz T, Robinson PN, Baasanjav S, Karow B, Gillessen-Kaesbach G, Fahsold R, Schmidt H, Hoffmann K, Passarge E (2010) Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3\u2019 terminus of the FBN1-gene. Am J Med Genet A 152A:2749\u20132755. https:\/\/doi.org\/10.1002\/ajmg.a.33690","journal-title":"Am J Med Genet A"},{"key":"386_CR83","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1042\/BJ20151108","volume":"473","author":"SA Jensen","year":"2016","unstructured":"Jensen SA, Handford PA (2016) New insights into the structure, assembly and biological roles of 10\u201312 nm connective tissue microfibrils from fibrillin-1 studies. Biochem J 473:827\u2013838. https:\/\/doi.org\/10.1042\/BJ20151108","journal-title":"Biochem J"},{"key":"386_CR84","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12079-020-00566-3","volume":"14","author":"ML Muthu","year":"2020","unstructured":"Muthu ML, Reinhardt DP (2020) Fibrillin-1 and fibrillin-1-derived asprosin in adipose tissue function and metabolic disorders. J Cell Commun Signal 14:159\u2013173. https:\/\/doi.org\/10.1007\/s12079-020-00566-3","journal-title":"J Cell Commun Signal"},{"key":"386_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1023","volume":"8","author":"M Lin","year":"2020","unstructured":"Lin M, Liu Z, Liu G et al (2020) Genetic and molecular mechanism for distinct clinical phenotypes conveyed by allelic truncating mutations implicated in FBN1. Mol Genet Genomic Med 8:e1023. https:\/\/doi.org\/10.1002\/mgg3.1023","journal-title":"Mol Genet Genomic Med"},{"key":"386_CR86","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1093\/hmg\/ddu224","volume":"23","author":"JG Buchan","year":"2014","unstructured":"Buchan JG, Alvarado DM, Haller GE et al (2014) Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. Hum Mol Genet 23:5271\u20135282. https:\/\/doi.org\/10.1093\/hmg\/ddu224","journal-title":"Hum Mol Genet"},{"key":"386_CR87","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere C, Duerrschmid C, Bournat J et al (2016) Asprosin, a fasting-induced glucogenic protein hormone. Cell 165:566\u2013579. https:\/\/doi.org\/10.1016\/j.cell.2016.02.063","journal-title":"Cell"},{"key":"386_CR88","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1097\/TP.0b013e31817b00c2","volume":"85","author":"R Verzaro","year":"2008","unstructured":"Verzaro R, Minervini M, Gridelli B (2008) Toward \u201cno age limit\u201d for liver transplant donors. Transplantation 85:1869\u20131870. https:\/\/doi.org\/10.1097\/TP.0b013e31817b00c2","journal-title":"Transplantation"},{"key":"386_CR89","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/ncb1708","volume":"10","author":"P Scaffidi","year":"2008","unstructured":"Scaffidi P, Misteli T (2008) Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol 10:452\u2013459. https:\/\/doi.org\/10.1038\/ncb1708","journal-title":"Nat Cell Biol"},{"key":"386_CR90","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13116","volume":"19","author":"J Tu","year":"2020","unstructured":"Tu J, Wan C, Zhang F, Cao L, Law PWN, Tian Y, Lu G, Rennert OM, Chan WY, Cheung HH (2020) Genetic correction of Werner syndrome gene reveals impaired pro-angiogenic function and HGF insufficiency in mesenchymal stem cells. Aging Cell 19:e13116. https:\/\/doi.org\/10.1111\/acel.13116","journal-title":"Aging Cell"},{"key":"386_CR91","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.stemcr.2014.02.006","volume":"2","author":"HH Cheung","year":"2014","unstructured":"Cheung HH, Liu X, Canterel-Thouennon L, Li L, Edmonson C, Rennert OM (2014) Telomerase protects werner syndrome lineage-specific stem cells from premature aging. Stem Cell Rep 2:534\u2013546. https:\/\/doi.org\/10.1016\/j.stemcr.2014.02.006","journal-title":"Stem Cell Rep"},{"key":"386_CR92","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/jpm11101043","volume":"11","author":"A Infante","year":"2021","unstructured":"Infante A, Rodr\u00edguez CI (2021) Cell and cell-free therapies to counteract human premature and physiological aging: MSCs come to light. J Pers Med 11:1043. https:\/\/doi.org\/10.3390\/jpm11101043","journal-title":"J Pers Med"},{"issue":"2","key":"386_CR93","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3892\/or.2011.1295","volume":"26","author":"Z Guo","year":"2011","unstructured":"Guo Z, He Y, Wang S, Zhang A, Zhao P, Gao C, Cao B (2011) Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells. Oncol Rep 26(2):511\u2013517. https:\/\/doi.org\/10.3892\/or.2011.1295","journal-title":"Oncol Rep"},{"key":"386_CR94","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/15548627.2015.1017192","volume":"11","author":"L You","year":"2015","unstructured":"You L, Wang Z, Li H, Shou J, Jing Z, Xie J, Sui X, Pan H, Han W (2015) The role of STAT3 in autophagy. Autophagy 11:729\u2013739. https:\/\/doi.org\/10.1080\/15548627.2015.1017192","journal-title":"Autophagy"},{"key":"386_CR95","doi-asserted-by":"publisher","unstructured":"Cohen PR, Tomson BN, Elkin SK, Marchlik E, Carter JL, Razelle Kurzrock (2016) Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics. Oncotarget 7:23454\u201367. https:\/\/doi.org\/10.18632\/oncotarget.8032","DOI":"10.18632\/oncotarget.8032"},{"key":"386_CR96","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1001\/jama.2018.3264","volume":"319","author":"LB Gordon","year":"2018","unstructured":"Gordon LB, Shappell H, Massaro J, D\u2019Agostino RB Sr, Brazier J, Campbell SE, Kleinman ME, Kieran MW (2018) Association of lonafarnib treatment vs no treatment with mortality rate in patients with Hutchinson-Gilford progeria syndrome. JAMA 319:1687\u20131695. https:\/\/doi.org\/10.1001\/jama.2018.3264","journal-title":"JAMA"},{"key":"386_CR97","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12020-014-0450-4","volume":"49","author":"D Araujo-Vilar","year":"2015","unstructured":"Araujo-Vilar D, S\u00e1nchez-Iglesias S, Guill\u00edn-Amarelle C et al (2015) Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience. Endocrine 49:139\u2013147. https:\/\/doi.org\/10.1007\/s12020-014-0450-4","journal-title":"Endocrine"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00386-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-022-00386-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00386-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T01:26:37Z","timestamp":1669857997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-022-00386-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["386"],"URL":"https:\/\/doi.org\/10.1007\/s42000-022-00386-7","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"assertion":[{"value":"13 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.A-V has received fees for talks and CME from Amryt Pharma; the other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}